EE644 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the US
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.909
https://www.valueinhealthjournal.com/article/S1098-3015(23)04039-1/fulltext
Title :
EE644 Budget Impact of Oral Nirmatrelvir/Ritonavir in Patients at High Risk for Progression to Severe COVID-19 in the US
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)04039-1&doi=10.1016/j.jval.2023.09.909
First page :
Section Title :
Open access? :
No
Section Order :
10400